Tirzepatide is technically the combination of two different drugs: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Because of this, Tirzepatide is also known as a dual GLP-1/GIP receptor agonist. These are both hormones that your system releases after you eat
So if you add up the fact that, okay, semaglutide, and I'm not picking on semaglutide, it could be any one of those synthetic incretins
And thats something very valuable that a lot of clinicians should take advantage of
What diagnosis codes help with GLP-1 insurance approval
[DOI] [PubMed] [Google Scholar] 283.Rodriguez P.J., Goodwin Cartwright B.M., Gratzl S., Brar R., Baker C., Gluckman T.J., Stucky N.L